Phase I Study of the Pharmacodynamics and Safety of Sodium Zirconium Cyclosilicate in Healthy Chinese Adults

Sodium zirconium cyclosilicate (SZC) is an effective potassium binder for patients with hyperkalemia. This single‐center, open‐label, phase I study (NCT03283267) characterized the pharmacodynamics and safety of SZC in Chinese individuals. Twenty‐two healthy Chinese adults (mean age, 33.5 years) rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Tommy, Sun, Fang, Zhao, June, Qin, Yulin, Någård, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303228/
https://www.ncbi.nlm.nih.gov/pubmed/34997825
http://dx.doi.org/10.1002/cpdd.1055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303228/
https://www.ncbi.nlm.nih.gov/pubmed/34997825
http://dx.doi.org/10.1002/cpdd.1055

Ejemplares similares